{
  "ticker": "IMM",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02973179",
  "id": "02973179",
  "pages": 2,
  "price_sensitive": false,
  "date": "20250728",
  "time": "0927",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250728/pdf/06m6btjm0ft3b0.pdf",
  "summary": "- **Clinical Data Presentations**: Three abstracts accepted for ESMO Congress 2025, including:  \n  - **EFTISARC-NEO Phase II trial** (resectable soft tissue sarcoma) \u2013 Proffered Paper oral presentation (19 Oct 2025).  \n  - **INSIGHT-003 Phase I trial** (1L NSCLC) \u2013 Poster presentation (18 Oct 2025).  \n  - **TACTI-004 Phase III trial** (1L NSCLC) \u2013 Trials in Progress ePoster.  \n- **Abstract Availability**: Abstracts to be published on ESMO website (13 Oct 2025).  \n\n**No material trading or capital markets impact identified** (operational update only).",
  "usage": {
    "prompt_tokens": 1207,
    "completion_tokens": 146,
    "total_tokens": 1353,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-27T23:35:10.773670"
}